Literature DB >> 18697204

Altered hepatic triglyceride content after partial hepatectomy without impaired liver regeneration in multiple murine genetic models.

Elizabeth P Newberry1, Susan M Kennedy, Yan Xie, Jianyang Luo, Susan E Stanley, Clay F Semenkovich, Roseanne M Crooke, Mark J Graham, Nicholas O Davidson.   

Abstract

UNLABELLED: Liver regeneration is impaired following partial hepatectomy (PH) in mice with genetic obesity and hepatic steatosis and also in wild-type mice fed a high-fat diet. These findings contrast with other data showing that liver regeneration is impaired in mice in which hepatic lipid accumulation is suppressed by either pharmacologic leptin administration or by disrupted glucocorticoid signaling. These latter findings suggest that hepatic steatosis may actually be required for normal liver regeneration. We have reexamined this relationship using several murine models of altered hepatic lipid metabolism. Liver fatty acid (FA) binding protein knockout mice manifested reduced hepatic triglyceride (TG) content compared to controls, with no effect on liver regeneration or hepatocyte proliferation. Examination of early adipogenic messenger RNAs revealed comparable induction in liver from both genotypes despite reduced hepatic steatosis. Following PH, hepatic TG was reduced in intestine-specific microsomal TG transfer protein deleter mice, which fail to absorb dietary fat, increased in peroxisome proliferator activated receptor alpha knockout mice, which exhibit defective FA oxidation, and unchanged (from wild-type mice) in liver-specific FA synthase knockout mice in which endogenous hepatic FA synthesis is impaired. Hepatic TG increased in the regenerating liver in all models, even in animals in which lipid accumulation is genetically constrained. However, in no model -- and over a >90-fold range of hepatic TG content -- was liver regeneration significantly impaired following PH.
CONCLUSION: Although hepatic TG content is widely variable and increases during liver regeneration, alterations in neither exogenous or endogenous lipid metabolic pathways, demonstrated to promote or diminish hepatic steatosis, influence hepatocyte proliferation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18697204      PMCID: PMC2577767          DOI: 10.1002/hep.22473

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  32 in total

1.  The effect of microvesicular fatty change on liver regeneration after partial hepatectomy.

Authors:  M S Rao; J K Reddy
Journal:  Hepatogastroenterology       Date:  2000 Jul-Aug

2.  Caveolin-1 is essential for liver regeneration.

Authors:  Manuel A Fernández; Cecilia Albor; Mercedes Ingelmo-Torres; Susan J Nixon; Charles Ferguson; Teymuras Kurzchalia; Francesc Tebar; Carlos Enrich; Robert G Parton; Albert Pol
Journal:  Science       Date:  2006-09-15       Impact factor: 47.728

3.  Impaired Ras membrane association and activation in PPARalpha knockout mice after partial hepatectomy.

Authors:  Michael D Wheeler; Olivia M Smutney; Jennifer F Check; Ivan Rusyn; R Schulte-Hermann; Ronald G Thurman
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2002-10-16       Impact factor: 4.052

4.  Disruption of hepatic adipogenesis is associated with impaired liver regeneration in mice.

Authors:  Eyal Shteyer; Yunjun Liao; Louis J Muglia; Paul W Hruz; David A Rudnick
Journal:  Hepatology       Date:  2004-12       Impact factor: 17.425

5.  Activation of peroxisome proliferator-activated receptor alpha increases the expression and activity of microsomal triglyceride transfer protein in the liver.

Authors:  Caroline Améen; Ulrika Edvardsson; Anna Ljungberg; Lennart Asp; Peter Akerblad; Anna Tuneld; Sven-Olof Olofsson; Daniel Lindén; Jan Oscarsson
Journal:  J Biol Chem       Date:  2004-11-09       Impact factor: 5.157

6.  Leptin-specific mechanisms for impaired liver regeneration in ob/ob mice after toxic injury.

Authors:  Isabelle A Leclercq; Jacqueline Field; Geoffrey C Farrell
Journal:  Gastroenterology       Date:  2003-05       Impact factor: 22.682

7.  Dispensability and dynamics of caveolin-1 during liver regeneration and in isolated hepatic cells.

Authors:  Rafael Mayoral; Amalia Fernández-Martínez; Rosa Roy; Lisardo Boscá; Paloma Martín-Sanz
Journal:  Hepatology       Date:  2007-09       Impact factor: 17.425

8.  Decreased hepatic triglyceride accumulation and altered fatty acid uptake in mice with deletion of the liver fatty acid-binding protein gene.

Authors:  Elizabeth P Newberry; Yan Xie; Susan Kennedy; Xianlin Han; Kimberly K Buhman; Jianyang Luo; Richard W Gross; Nicholas O Davidson
Journal:  J Biol Chem       Date:  2003-10-08       Impact factor: 5.157

9.  Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators.

Authors:  S S Lee; T Pineau; J Drago; E J Lee; J W Owens; D L Kroetz; P M Fernandez-Salguero; H Westphal; F J Gonzalez
Journal:  Mol Cell Biol       Date:  1995-06       Impact factor: 4.272

10.  c-Jun/AP-1 controls liver regeneration by repressing p53/p21 and p38 MAPK activity.

Authors:  Ewa Stepniak; Romeo Ricci; Robert Eferl; Grzegorz Sumara; Izabela Sumara; Martina Rath; Lijian Hui; Erwin F Wagner
Journal:  Genes Dev       Date:  2006-08-15       Impact factor: 11.361

View more
  55 in total

Review 1.  Liver fatty acid-binding protein and obesity.

Authors:  Barbara P Atshaves; Gregory G Martin; Heather A Hostetler; Avery L McIntosh; Ann B Kier; Friedhelm Schroeder
Journal:  J Nutr Biochem       Date:  2010-11       Impact factor: 6.048

2.  Direct comparison of mice null for liver or intestinal fatty acid-binding proteins reveals highly divergent phenotypic responses to high fat feeding.

Authors:  Angela M Gajda; Yin Xiu Zhou; Luis B Agellon; Susan K Fried; Sarala Kodukula; Walter Fortson; Khamoshi Patel; Judith Storch
Journal:  J Biol Chem       Date:  2013-08-29       Impact factor: 5.157

3.  Liver Regeneration Is Impaired in Mice with Acute Exposure to a Very Low Carbohydrate Diet.

Authors:  Hao Chen; Yandie Lin; Wu Sun; Yun Cai; Hao Li
Journal:  Dig Dis Sci       Date:  2017-03-06       Impact factor: 3.199

Review 4.  Elucidating the metabolic regulation of liver regeneration.

Authors:  Jiansheng Huang; David A Rudnick
Journal:  Am J Pathol       Date:  2013-10-17       Impact factor: 4.307

5.  Retinoic Acid-mediated Nuclear Receptor Activation and Hepatocyte Proliferation.

Authors:  Nathan Bushue; Yu-Jui Yvonne Wan
Journal:  J Exp Clin Med       Date:  2009-12

6.  Ablating both Fabp1 and Scp2/Scpx (TKO) induces hepatic phospholipid and cholesterol accumulation in high fat-fed mice.

Authors:  Sherrelle Milligan; Gregory G Martin; Danilo Landrock; Avery L McIntosh; John T Mackie; Friedhelm Schroeder; Ann B Kier
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2018-01-04       Impact factor: 4.698

Review 7.  Update on the Mechanisms of Liver Regeneration.

Authors:  Morgan E Preziosi; Satdarshan P Monga
Journal:  Semin Liver Dis       Date:  2017-05-31       Impact factor: 6.115

8.  Resveratrol Improves Recovery and Survival of Diet-Induced Obese Mice Undergoing Extended Major (80%) Hepatectomy.

Authors:  Xiaoling Jin; Teresa A Zimmers; Zongxiu Zhang; Leonidas G Koniaris
Journal:  Dig Dis Sci       Date:  2018-10-03       Impact factor: 3.199

9.  Impaired liver regeneration in Ldlr-/- mice is associated with an altered hepatic profile of cytokines, growth factors, and lipids.

Authors:  Montse Pauta; Noemi Rotllan; Frances Vales; Ana Fernandez-Hernando; Ryan M Allen; David A Ford; Montserrat Marí; Wladimiro Jiménez; Angel Baldán; Manuel Morales-Ruiz; Carlos Fernández-Hernando
Journal:  J Hepatol       Date:  2013-05-24       Impact factor: 25.083

10.  Impaired cell proliferation in regenerating liver of 3 β-hydroxysterol Δ14-reductase (TM7SF2) knock-out mice.

Authors:  Daniela Bartoli; Danilo Piobbico; Marina Maria Bellet; Anna Maria Bennati; Rita Roberti; Maria Agnese Della Fazia; Giuseppe Servillo
Journal:  Cell Cycle       Date:  2016-06-24       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.